TSX:LMAX Holdings Information

TSX:LMAX is an equity ETF with a total of 22 individual holdings. The top holdings are Eli Lilly and Company stock at 5.72%, Regeneron Pharmaceuticals at 5.54%, Amgen at 5.46%, Gilead Sciences at 5.37%, and AbbVie at 5.25%.

Total Holdings

Top 10 Percentage

53.14%

Asset Class

Equity

ETF Category

Health Care

Assets

253.72M

PE Ratio

27.70

Breakdown by Country

Top 25 Holdings

Updated Oct 31, 2026

No.	Symbol	Name	Weight% Weight	Shares	Stock Price	% Change
1	LLY	Eli Lilly and Company	5.72%	7,324	1,411.95	4.28%
2	REGN	Regeneron Pharmaceuticals, Inc.	5.54%	10,846	919.96	1.73%
3	AMGN	Amgen Inc.	5.46%	21,268	465.23	1.04%
4	GILD	Gilead Sciences, Inc.	5.37%	57,094	169.32	1.46%
5	ABBV	AbbVie Inc.	5.25%	32,340	293.30	0.68%
6	PFE	Pfizer Inc.	5.23%	311,063	29.23	-0.54%
7	VRTX	Vertex Pharmaceuticals Incorporated	5.20%	16,878	550.87	0.69%
8	MDT	Medtronic plc	5.15%	96,891	102.79	0.97%
9	UNH	UnitedHealth Group Incorporated	5.14%	22,916	397.62	0.88%
10	DHR	Danaher Corporation	5.09%	39,797	235.12	2.12%
11	ISRG	Intuitive Surgical, Inc.	5.07%	21,313	460.56	1.71%
12	MCK	McKesson Corporation	5.03%	9,188	1,059.37	-0.14%
13	TMO	Thermo Fisher Scientific Inc.	5.03%	13,090	721.63	3.87%
14	SYK	Stryker Corporation	4.98%	30,951	325.73	-0.04%
15	CVS	CVS Health Corporation	4.92%	98,916	85.25	1.67%
16	ABT	Abbott Laboratories	4.90%	83,845	110.51	0.53%
17	ELV	Elevance Health, Inc.	4.89%	21,149	418.25	-1.73%
18	JNJ	Johnson & Johnson	4.81%	31,988	282.11	2.13%
19	MRK	Merck & Co., Inc.	4.75%	57,632	148.76	1.38%
20	BMY	Bristol-Myers Squibb Company	4.72%	137,019	62.14	-
21	n/a	Cash And Other Assets/Liabilities	-0.77%	1,957,166	-	-
22	n/a	Written Call Options	-1.47%	-	-	-